Description

Attending the MedTech Conference in Boston? LEK is hosting cocktails, networking, and a distinguished group of panelists. Topic: MedTech has long been valued for its durable growth and attractive margins, but sector valuations have come under increasing pressure. We're bringing together senior leaders from across the industry for a candid discussion on what's driving the valuation pressure and volatility, where the next wave of value creation and valuation reset may come from, as well as the role of the recent wave of special situations such as carve-outs and take-privates. Panel participants include: Matt Dolan: EVP, Strategy & Corporate Development at Dexcom Rachel Ellingson: Chief Strategy & Corporate Development Officer at Solventum Gabriela Kaynor: Executive Officer & Chief Strategy Officer at Olympus Corporation Vishva Mehta: Principal, Healthcare & Life Sciences at Blackstone André-Michel Ballester: Managing Partner, MedTech at Archimed Contact: k.stehlik@lek.com for more information and registration